Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
237 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bcca-Vancouver Island Cancer Centre
Victoria, British Columbia, Canada
- Ottawa Hospital and Cancer Center-General Campus
Ottawa, Ontario, Canada
- Windsor Regional Cancer Centre
Windsor, Ontario, Canada
- Chum - Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- the Research Institute of the Mcgill University Health Centre (muhc)
Montreal, Quebec, Canada
- Chu de Quebec-L'Hotel-Dieu de Quebec (hdq)
Québec, Quebec, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Arizona Oncology Associates-West Orange Grove
Tucson, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Ais Cancer Center at San Joaquin Community Hospital
Bakersfield, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Fresno Cancer Center
Fresno, California, United States
- Marin General Hospital
Greenbrae, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Memorial Medical Center
Modesto, California, United States
- Kaiser Permanente Oakland-Broadway
Oakland, California, United States
- Saint Joseph Hospital - Orange
Orange, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Pomona Valley Hospital Medical Center
Pomona, California, United States
- Kaiser Permanente-Rancho Cordova Cancer Center
Rancho Cordova, California, United States
- Rohnert Park Cancer Center
Rohnert Park, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Roseville
Roseville, California, United States
- the Permanente Medical Group-Roseville Radiation Oncology
Roseville, California, United States
- South Sacramento Cancer Center
Sacramento, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Dec 2014
- Primary completion
- 7 Jul 2025
- Completion
- 31 Dec 2026
- Last update posted
- 14 Jan 2026
- Registered enrollment
- 606
- Registry id
- NCT02179086
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.